entertainment -WSS

entertainment

author：fashion 2025-09-28 01:16:49 - browse：92

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. For comparison, there were roughly 2,122 financing deals made last year.

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Eli Lilly CEO gives to Mike Pence presidential super PAC

hotspot

knowledge

WSS

Ionis has late

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

PBMs drew scrutiny in House hearing — and so did pharma

White House Covid adviser calls on docs to combat misinformation

People with substance use disorder deserve online privacy

hotspot

entertainment

focus

What does generative AI mean for health care? We asked experts

Ionis has late

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare drug price negotiation program allowed for now

Apple is now the first public company to be valued at $3 trillion

Did you have Obamacare on your GOP debate bingo card?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare to pay more for cardiac rehab in hospital outpatient clinics

hotspot

WHO recommends dropping component of many flu vaccines

Neurocrine congenital adrenal hyperplasia trial succeeds

Address the ethical violations that led to 'Three Identical Strangers'

Assistant physicians can help address the primary care shortage

Biogen shutters digital health group, ends Apple study, in cost cutting move

David Liu startup to focus on CRISPR delivery

hotspot

knowledge

leisure time

focus